Inactive Instrument

Magicstem Group Corp.

Equities

MGGI

US55917N1054

Biotechnology & Medical Research

Magicstem Group Corp. Appoints Fong-Sze Hung to the Board

October 17, 2016 at 06:07 am EDT

Magicstem Group Corp. entered into a share exchange agreement, with the Info-Nice Limited and its sole shareholder, Mr. Fong-Sze Hung, pursuant to closing, Mr. Mr. Fong-Sze Fong was duly appointed to the Board of Directors of the company.

Latest news about Magicstem Group Corp.

Fong Sze Hung Resigns as a Director of Magicstem Group Corp	17-02-24	CI
Magicstem Group Corp. Appoints Fong-Sze Hung to the Board	16-10-17	CI
Magicstem Group Corp. completed the acquisition of Info-Nice Limited from Fong Sze Hung in stock.	16-10-10	CI
Magicstem Group Corp. entered into a share exchange agreement to acquire Info-Nice Limited from Fong Sze Hung.	16-09-25	CI
Magicstem Group Corp. Announces Executive Changes	16-04-07	CI
Magicstem Group Corp. Auditor Raises 'Going Concern' Doubt	16-01-28	CI
Magicstem Group Corp. Announces Executive Appointments	15-07-21	CI
Cold Cam, Inc. Announces Management Changes	15-02-06	CI

Chart Magicstem Group Corp.

Duration

Period

More charts

Company Profile

Magicstem Group Corp. is a development-stage company. The Company focuses on developing stem cell cryo-preserved banking with a focus on customers in China. It operates through the Hong Kong segment. The Company, through its subsidiary, Info Nice Limited, is engaged in the provision of agency and distribution of stem cell cryo-preserved banking service in Asia and Pacific (APAC) Region. It focuses on customers from APAC Region willing to cryo-preserve, on a long-term basis, their own mesenchymal stem cells that could be harvested from various types of the customer's human body tissue, including placenta and dental pulp. The mesenchymal stem cells cryopreservation services and cell banking facilities that Info-Nice Limited distributes is operating under the brand name, Asia Stem Cell Bank, and is located in Shanghai International Medical Zone, Shanghai City, People's Republic of China. As of October 31, 2016, the Company had not generated any revenue from its operations.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+55.55%	59.34B
LONZA GROUP AG	+43.17%	40.24B
IQVIA HOLDINGS INC.	-4.71%	39.88B
CELLTRION, INC.	-5.56%	28.55B
ICON PUBLIC LIMITED COMPANY	+13.76%	27.26B
ALNYLAM PHARMACEUTICALS, INC.	-22.00%	19.23B
MEDPACE HOLDINGS, INC.	+31.50%	12.61B
BIO-TECHNE CORPORATION	+2.16%	12.49B
UNITED THERAPEUTICS CORPORATION	+25.70%	12.28B

Other Biotechnology & Medical Research